- Home
- TOST vs PODD Comparison
TOST vs PODD Comparison
Compare TOST & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOST
- PODD
- Stock Information
- Founded
- TOST 2012
- PODD 2000
- Country
- TOST United States
- PODD United States
- Employees
- TOST N/A
- PODD N/A
- Industry
- TOST EDP Services
- PODD Medical/Dental Instruments
- Sector
- TOST Technology
- PODD Health Care
- Exchange
- TOST Nasdaq
- PODD Nasdaq
- Market Cap
- TOST 26.3B
- PODD 23.8B
- IPO Year
- TOST 2021
- PODD 2007
- Fundamental
- Price
- TOST $41.43
- PODD $333.51
- Analyst Decision
- TOST Buy
- PODD Strong Buy
- Analyst Count
- TOST 24
- PODD 18
- Target Price
- TOST $45.42
- PODD $334.50
- AVG Volume (30 Days)
- TOST 7.9M
- PODD 571.8K
- Earning Date
- TOST 11-06-2025
- PODD 11-06-2025
- Dividend Yield
- TOST N/A
- PODD N/A
- EPS Growth
- TOST N/A
- PODD N/A
- EPS
- TOST 0.37
- PODD 3.32
- Revenue
- TOST $5,529,000,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- TOST $24.84
- PODD $29.13
- Revenue Next Year
- TOST $20.20
- PODD $18.13
- P/E Ratio
- TOST $111.71
- PODD $100.19
- Revenue Growth
- TOST 26.06
- PODD 26.00
- 52 Week Low
- TOST $26.18
- PODD $225.37
- 52 Week High
- TOST $49.66
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- TOST 45.59
- PODD 52.30
- Support Level
- TOST $39.45
- PODD $313.24
- Resistance Level
- TOST $41.02
- PODD $351.94
- Average True Range (ATR)
- TOST 1.21
- PODD 10.74
- MACD
- TOST -0.01
- PODD -3.18
- Stochastic Oscillator
- TOST 38.09
- PODD 50.35
About TOST Toast Inc.
Toast is an end-to-end technology platform designed to address the complex needs of the restaurant industry. The company generates point-in-time revenue through sales of its restaurant-grade hardware and recurring revenue in the form of take rates on restaurant transaction volume as well as subscriptions to its software solutions. As of fiscal 2024, the company provided services to 134,000 restaurant locations primarily in the US. Toast's typical customer is a mid-market restaurant generating slightly more than $1 million in revenue annually.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.